Toxic fungi.
Much progress in the areas of identification of active components and elucidation of the toxic mechanisms for the principal poisonous mushrooms has been made in the past decade. This affords a more rational approach to therapeutic management which has consequently resulted in a decrease in the morbidity and mortality associated with these species. However, the effectiveness of a large number of adjuvants for Amanita phalloides poisoning still needs critical laboratory evaluation. The current status of knowledge concerning the toxic potential and contituents of many mushroom species, including the gastroenteric irritants, is inadequate. The problem of geographic variation or genetic strain in the concentration of toxins of many species also requires further investigation. The recent awareness and interest in the pharmacology and toxicology of uncultivated mushrooms in North America and Great Britain should encourage continued active research.
D000546:Amanitins / Q000506:poisoning; D000818:Animals; D001487:Basidiomycota / Q000145:classification; D004221:Disulfiram / Q000494:pharmacology; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007509:Irritants; D009145:Mushroom Poisoning / Q000503:physiopathology*; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D011562:Psilocybin / Q000506:poisoning
D000546:Amanitins; D007509:Irritants; D011562:Psilocybin; D004221:Disulfiram